Xtandi 40 mg Soft Capsule
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Xtandi 40 mg Soft Capsule contains enzalutamide, an androgen receptor inhibitor. Its labelling describes it for the treatment of cancer of the prostate gland by blocking the effects of testosterone (the male hormone) on the growth of prostate cells. It is taken by mouth with or without food, at the same time each day.
Product Information
The following description reflects information associated with enzalutamide and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of cancer of the prostate gland
- Described as blocking the effects of testosterone on the growth of prostate cells
Described Dosage & Administration
- Taken by mouth with or without food, preferably at a fixed time each day, at the dose and duration set by the doctor
- The capsule should be taken correctly to avoid serious side effects; a double dose should not be taken
Described Side Effects
Commonly described side effects include:
- Headache
- Hot flushes
- Weakness and tiredness
- High blood pressure
- Decreased appetite
- Constipation
- Dry skin and itching
- Falls and fractures
These are described as commonly temporary. Any severe, persistent, or unexpected reaction — including a seizure — requires prompt medical attention.
Precautions
- The skin is described as becoming more sensitive to sunlight, so sun protection should be used outdoors
- The doctor should be told about any diabetes, seizures, or liver or kidney problems
- It is described as not for use by pregnant or breastfeeding women; effective contraception should be used
- Regular monitoring of blood glucose is described as carried out during treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains enzalutamide, an androgen receptor inhibitor used to treat cancer of the prostate gland by blocking the effects of testosterone on prostate cell growth. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth with or without food, preferably at a fixed time each day, at the dose and duration set by the doctor. A double dose should not be taken.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.